hecogenin has been researched along with Experimental Mammary Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ebrahim, HY; El Sayed, KA; Elsayed, HE; Haggag, EG; Kamal, AM | 1 |
1 other study(ies) available for hecogenin and Experimental Mammary Neoplasms
Article | Year |
---|---|
Rationally designed hecogenin thiosemicarbazone analogs as novel MEK inhibitors for the control of breast malignancies.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Female; Humans; Mammary Neoplasms, Experimental; MAP Kinase Kinase Kinases; Mice; Mice, Nude; Molecular Structure; Protein Kinase Inhibitors; Sapogenins; Structure-Activity Relationship; Thiosemicarbazones; Tumor Cells, Cultured | 2017 |